How often does Harmony Biosciences move more than the options market prices?

0 of the last 7 reports moved at least as far as the implied move.

HRMYNasdaqPharmaceutical Preparations

Harmony Biosciences Holdings, Inc. (HRMY) earnings date, market-implied expected move, and options open interest by expiry

34.38

−2.64 · −7.13%

Regular session09:50 ET

Open38.00Volume993,981Mkt cap$2.2BP/E10.95EPS3.14

Day34.00 – 38.009%52-wk25.90 – 43.4948%

HRMY

Harmony Biosciences Holdings, Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Expected move

Inputs

Next report

Feb 23

before open · in 111 days

est.Q4 FY26

Calendar

Next report

Last report

Nov 4

before open

confirmedNov 3 closethin chain

Implied vs realized

Largest filed tie

38.00%

of HRMY revenue · Caremark

customerHRMY 10-K

Supply chain

Largest filed tie

13F top-10 QoQ

+5.93%

shares held · 10 largest managers

13F · Jun 30 '26127d lag

323 managers

Top fund weight

0.05%

HRMY weight · IWM

N-PORTJun 30 '26

4 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Harmony Biosciences (HRMY) is expected to report on Feb 23 before open (estimated date).

Implied vs realized

8 reports

0 of 7≥ implied

avg implied: ±11.3%
avg realized: ±4.6%

Feb 25 '25Feb 25 '25confirmed—▲+8.16%—

May 6 '25May 6 '25confirmed±7.7%▲+6.98%×0.91

Aug 5 '25Aug 5 '25confirmed±13.0%▼−1.69%×0.13

Nov 4 '25Nov 4 '25confirmed±9.4%▲+4.74%×0.50

Jan 12 '26Jan 12 '26confirmed±8.4%▼−0.73%×0.09

Q1 FY26Feb 24 '26confirmed±14.4%▲+4.91%×0.34

May 7 '26May 7 '26confirmed±12.0%▼−4.15%×0.34

Q2 FY26Aug 4 '26confirmed±14.3%▲+8.93%×0.62

quarterimplied−15%0+15%realized×

Q2 FY26±14.3%▲+8.93%×0.62

May '26±12.0%

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 5 expiries · Nov 2 close

0.04OI · 5 expiries · Nov 2 closeP/C open interest · Apr 16 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

2 nearer expiries

2260%Nov 2016d1.052150%1.05

12,5090%Dec 1844d5.152,4280%5.15

1,329+60%Jan 1572d2.166150%2.16

0—Feb 19107d0.003+50%0.00

ExpiryPutsCallsP/C

2 nearer expiries

Nov 2016d2260%2150%1.05

Dec 1844d12,5090%2,4280%5.15

Jan 1572d1,329+60%615

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

No implied move.

Linked exposure

Revenue flow

as filedQ3 FY26

17.92%as filednet margin · revenue +2.92% QoQ · +12.30% YoY

Revenue

$269M+2.92% QoQ

Gross profit

$188M−4.97% QoQ

70.00% margin

Operating income

$54M−39.32% QoQ

20.15% margin

Pre-tax income

$59M−36.47% QoQ

Net income

$48M−36.11% QoQ

17.92% margin

Cost of revenue

$81M+27.67% QoQ

Operating expenses

$134M+23.23% QoQ

R&D $72M

Marketing $35M

SG&A $28M

Tax

$11M−38.02% QoQ

Other income

$5M+27.93% QoQ

Revenue$269M+2.92%

Gross profit

$188M−4.97%

70.00% margin

Operating income

$54M−39.32%

20.15% margin

Pre-tax income

$59M−36.47%

Net income

$48M−36.11%

17.92% margin

Cost of revenue

$81M+27.67%

Operating expenses

$134M+23.23%

R&D $72M

Marketing $35M

SG&A $28M

Other income$5M+27.93%

Tax$11M−38.02%

flow · deduction · inflow · signed % = QoQSource: SEC filings · standardized · QE Sep 30 '26 · width = $

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 09:45 ET

Intraday

Event sensitivity

PCE ×1.05· ±2.1% vs ±2.0% · 19 releases

eventrelease day|move|up · n×base

PCEpersonal income & outlays±2.1%10 of 19×1.05

CPIconsumer prices±1.9%5 of 10×0.99

GDPgross domestic product±1.6%11 of 19×0.83

NFPjobs report±1.5%4 of 10×0.78

FOMCrate decision±1.5%11 of 24×0.74

PPIproducer prices±1.4%4 of 10×0.71

CPROFcorporate profits±1.0%8 of 12×0.53

Bar = avg |move| to ±3% · tick = ±2.0% avg day · ×base = |move| ÷ ±2.0% · min 6 releases

Earnings history

EPS 0.81 · consensus —

Quarter	Reported	EPS	Consensus
Q3 FY26	—	0.81	—
Q2 FY26	Aug 4 '26 · confirmed	1.28	—
Q1 FY26	Feb 24 '26 · confirmed	0.55	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod